Graft versus host disease after liver transplantation - A single center experience and review of literature

Transplant International

Volumn 21, Issue 5, 2008, Pages 441-451

  Kohler, Sven ^a   Pascher, Andreas ^a   Junge, Guido ^a   Sauer, Igor M ^a   Nagy, Marion ^a   Schönemann, Constanze ^a   Koch, Martin ^a   Neumann, Ulf ^a   Pratschke, Johann ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chimerism; Graft versus host disease; Liver transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; FOSCARNET SODIUM; GANCICLOVIR; HEPARIN; METHYLPREDNISOLONE; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTHRALGIA; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; CHIMERA; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DEATH; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LIVER TRANSPLANTATION; MALE; MEDLINE; PLASMAPHERESIS; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; STEVENS JOHNSON SYNDROME; SYMPTOM;

ADULT; AGED; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 41749117505     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00625.x     Document Type: Article

References (69)

1. Taylor AL, Gibbs P, Bradley JA. Acute graft versus host disease following liver transplantation: the enemy within. Am J Transpl 2004 4 : 466.
2. Smith DM, Agura E, Netto G, et al. Liver transplant-associated graft-versus-host disease. Transplantation 2003 75 : 118.
3. Bolanos-Meade J, Vogelsang GB. Novel strategies for steroid-refractory acute graft-versus-host disease. Curr Opin Hematol 2005 12 : 40.
4. Burakoff S, Deeg J, Ferrara J, Atkinson K. Graft-versus-host disease. In : Brinkhous K, Stass S, eds. Haematology. New York, Basel : Marcel Dekker, Inc, 1990 : 816 pp.
5. Norris S, Collins C, Doherty DG, et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998 28 : 84.
6. Taylor AL, Gibbs P, Sudhindran S, et al. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation. Transplantation 2004 77 : 441.
7. Ferrara JLM. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematotherapy Stem Cell Res 2000 9 : 299.
8. Nagy M, Otremba P, Kruger C, et al. Optimization and validation of a fully automated silica-coated magnetic beads purification technology in forensics. Forensic Sci Int 2005 152 : 13.
9. Lehner F, Becker T, Sybrecht L, et al. Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression. Transplantation 2002 73 : 307.
10. Roberts JP, Ascher NL, Lake J, et al. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology 1991 14 : 274.
11. Pollack MS, Speeg KV, Callander NS, et al. Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis. Human Immunol 2005 66 : 28.
12. Romagnuolo J, Jewell LD, Kneteman NM, Bain VG. Graft-versus-host disease after liver transplantation complicated by systemic aspergillosis with pancarditis. Can J Gastroenterol 2000 14 : 637.
13. Bhaduri BR, Tan KC, Humphreys S, et al. Graft-versus-host disease after orthotopic liver transplantation in a child. Transplant Proc 1990 22 : 2378.
14. Provenzale JM, Graham ML. Reversible leukoencephalopathy associated with graft-versus-host disease: MR findings. Am J Neuro Rad 1995 17 : 1290.
15. Orlando G, Ferrant A, Schots R, et al. Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up. Transpl Int 2005 18 : 125.
16. Soejima Y, Shimada M, Suehiro T, et al. Graft-versus-host disease following living donor liver transplantation. Liver transplant 2004 10 : 460.
17. Chan EY, Larson AM, Gernsheimer TB, et al. Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients. Liver Transpl 2007 13 : 516.
18. Soderberg C, Larsson S, Rozell BL, Sumitran-Karuppan S, Ljungman P, Moller E. Cytomegalovirus-induced CD13-specific autoimmunity - a possible cause of chronic graft-vs-host disease. Transplantation 1996 61 : 600.
19. Deeg HJ. Graft-versus-host disease and the development of late complications. Transfus Sci 1994 15 : 243.
20. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986 153 : 478.
21. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 2003 54 : 29.
22. Hings IM, Filipovich AH, Miller WJ, et al. Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial. Transplantation 1993 56 : 577.
23. Khoury H, Kashyap A, Adkins DR, et al. Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplant 2001 27 : 1059.
24. McCaul KG, Nevill TJ, Barnett MJ, et al. Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin. J Hematother Stem Cell Res 2000 9 : 367.
25. Remberger M, Aschan J, Barkholt L, Tollemar J, Ringden O. Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin. Clin Transplant 2001 15 : 147.
26. Sudhindran S, Taylor A, Delriviere L, et al. Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection. Am J Transplant 2003 3 : 1024.
27. Rinon M, Maruri N, Arrieta A, Fernandez JR, Ortiz de Urbina J, Garcia Masdevall MD. Selective immunosuppression with daclizumab in liver transplantation with graft-versus-host disease. Transplant Proc 2002 34 : 109.
28. Massenkeil G, Rackwitz S, Genvresse I, Rosen O, Dorken B, Arnold R. Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2002 30 : 899.
29. Przepiorka D, Kernan NA, Ippoliti C, et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood 2000 95 : 83.
30. Willenbacher W, Basara N, Blau IW, Fauser AA, Kiehl MG. Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab. Br J Haematol 2001 112 : 820.
31. Kobbe G, Schneider P, Rohr U, et al. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody. Bone Marrow Transplant 2001 28 : 47.
32. Jacobsohn DA, Hallick J, Anders V, McMillan S, Morris L, Vogelsang GB. Infliximab for steroid-refractory acute GVHD: a case series. Am J Hematol 2003 74 : 119.
33. Wang B, Lu Y, Yu L, Liu C, Wu Z, Liu X. Diagnosis and treatment for graft-versus-host disease after liver transplantation: two case reports. Transplant Proc 2007 39 : 1696.
34. Junge G, Neumann UP, Joka M, et al. Microchimerism in patients after orthotopic liver transplantation: a prognostic indicator? Transplant Proc 2002 34 : 1542.
35. Key T, Taylor CJ, Bradley JA, Taylor AL. Recipients who receive a human leukocyte antigen-B compatible cadaveric liver allograft are at high risk of developing acute graft-versus-host disease. Transplantation 2004 78 : 1809.
36. Perri R, Assi M, Talwalkar J, et al. Graft vs. host disease after liver transplantation: a new approach is needed. Liver Transpl 2007 13 : 1092.
37. Kamei H, Oike F, Fujimoto Y, Yamamoto H, Tanaka K, Kiuchi T. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching. Liver Transpl 2006 12 : 140.
38. Chinnakotla S, Smith DM, Domiati-Saad R, et al. Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management. Liver Transpl 2007 13 : 157.
39. Burdick JF, Vogelsang GB, Smith WJ, et al. Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med 1988 318 : 689.
40. Marubayashi S, Matsuzaka C, Takeda A, et al. Fatal generalized acute graft-versus-host disease in a liver transplant recipient. Transplantation 1990 50 : 709.
41. Merle C, Blanc D, Flesch M, Carbillet JP, Miguet JP, Gillet M. A picture of epidermal necrolysis after hepatic allograft. Etiologic aspects. Ann Dermatol Venereol 1990 117 : 635.
42. Jamieson NV, Joysey V, Friend PJ, et al. Graft-versus-host disease in solid organ transplantation. Transpl Int 1991 4 : 67.
43. Comenzo RL, Malachowski ME, Rohrer RJ, Freeman RB, Rabson A, Berkman EM. Anomalous ABO phenotype in a child after an ABO-incompatible liver transplantation. N Engl J Med 1992 326 : 867.
44. Collins RH, Jr., Cooper B, Nikaein A, Klintmalm G, Fay JW. Graft-versus-host disease in a liver transplant recipient. Ann Intern Med 1992 116 : 391.
45. DePaoli AM, Bitran J. Graft-versus-host disease and liver transplantation. Ann Intern Med 1992 117 : 170.
46. Joysey VC, Wood H, Ramsbottom S, et al. Lymphocyte chimaerism after organ transplantation. Transplant Proc 1992 24 : 2519.
47. Mazzaferro V, Andreola S, Regalia E, et al. Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing. Transplantation 1993 55 : 423.
48. Rosen GB, Ng CS, Moore SB. Clinical and pathological features of graft-versus-host disease after liver transplantation: a case report and review of the literature. Clin Transplant 1993 7 : 52.
49. Redondo P, Espana A, Herrero JI, et al. Graft-versus-host disease after liver transplantation. J Am Acad Dermatol 1993 29 : 314.
50. Neumann UP, Kaisers U, Langrehr JM, et al. Fatal graft-versus-host- disease: a grave complication after orthotopic liver transplantation. Transplant Proc 1994 26 : 3616.
51. Cattral MS, Langnas AN, Wisecarver JL, et al. Survival of graft-versus-host disease in a liver transplant recipient. Transplantation 1994 57 : 1271.
52. Pageaux GP, Perrigault PF, Fabre JM, et al. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism. Clin Transplant 1995 9 : 65.
53. Connors J, Drolet B, Walsh J, Crosby DL, Esterly NB. Morbilliform eruption in a liver transplantation patient. Arch Dermatol 1996 132 : 1161.
54. Sanchez-Izquierdo JA, Lumbreras C, Colina F, et al. Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: report of a case and literature review. Hepatogastroenterology 1996 43 : 1057.
55. Whitington PF, Rubin CM, Alonso EM, et al. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor. Transplantation 1996 62 : 1516.
56. Burt M, Jazwinska E, Lynch S, et al. Detection of circulating donor deoxyribonucleic acid by microsatellite analysis in a liver transplant recipient. Liver Transpl Surg 1996 2 : 391.
57. Kiuchi T, Harada H, Matsukawa H, et al. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation. Transpl Int 1998 11 (Suppl. 1 383.
58. Aziz H, Trigo P, Lendoire J, et al. Successful treatment of graft-vs-host disease after a second liver transplant. Transplant Proc 1998 30 : 2891.
59. Paizis G, Tait BD, Kyle P, Angus PW, Grigg AP. Successful resolution of severe graft versus host disease after liver transplantation correlating with disappearance of donor DNA from the peripheral blood. Aust N Z J Med 1998 28 : 830.
60. Schmuth M, Vogel W, Weinlich G, Margreiter R, Fritsch P, Sepp N. Cutaneous lesions as the presenting sign of acute graft-versus-host disease following liver transplantation. British J Dermatol 1999 141 : 901.
61. Joseph JM, Mosimann F, Tiercy JM, et al. PCR confirmation of microchimerism and diagnosis of graft versus host disease after liver transplantation. Transpl Int 1999 12 : 468.
62. Merhav HJ, Landau M, Gat A, et al. Graft versus host disease in a liver transplant patient with hepatitis B and hepatocellular carcinoma. Transplant Proc 1999 31 : 1890.
63. Hahn AB, Baliga P. Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation. Liver Transpl 2000 6 : 180.
64. Hanaway MJ, Buell JF, Musat AI. Graft-versus-host disease in solid organ transplant. Graft 2001 4 : 205.
65. Knox KS, Behnia M, Smith LR, et al. Acute graft-versus-host disease of the lung after liver transplantation. Liver Transpl 2002 8 : 968.
66. Hara H, Ohdan H, Tashiro H, et al. Differential diagnosis between graft-versus-host disease and hemophagocytic syndrome after living-related liver transplantation by mixed lymphocyte reaction assay. J Invest Surg 2004 17 : 197.
67. Domiati-Saad R, Klintmalm GB, Netto G, Agura ED, Chinnakotla S, Smith DM. Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism. Am J Transplant 2005 5 : 2968.
68. Whalen JG, Jukic DM, English JC, III. Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation. J Am Acad Dermatol 2005 52 : 908.
69. Schrager JJ, Vnencak-Jones CL, Graber SE, et al. Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients. Transplantation 2006 81 : 21.